众生药业跌2.02%，成交额3.53亿元，主力资金净流出5695.40万元

Core Viewpoint - The stock of Zhongsheng Pharmaceutical has experienced a decline of 2.02% on December 18, with significant trading activity and a notable year-to-date increase of 62.01% despite recent short-term declines [1][2]. Group 1: Stock Performance - As of December 18, Zhongsheng Pharmaceutical's stock price is 19.36 CNY per share, with a market capitalization of 16.455 billion CNY [1]. - The stock has seen a year-to-date increase of 62.01%, but has declined by 6.97% over the last five trading days, 16.84% over the last 20 days, and 3.68% over the last 60 days [1]. - The company has appeared on the trading leaderboard eight times this year, with the most recent appearance on November 28, where it recorded a net buy of -277 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Zhongsheng Pharmaceutical reported a revenue of 1.889 billion CNY, a year-on-year decrease of 1.01%, while the net profit attributable to shareholders increased by 68.40% to 251 million CNY [2]. - The company has distributed a total of 2.019 billion CNY in dividends since its A-share listing, with 502 million CNY distributed over the past three years [3]. Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders for Zhongsheng Pharmaceutical is 72,900, a decrease of 18.90% from the previous period, with an average of 10,445 circulating shares per shareholder, an increase of 23.31% [2]. - The top ten circulating shareholders include Hong Kong Central Clearing Limited, which holds 22.647 million shares, an increase of 13.474 million shares from the previous period [3].